Skip to main content
High RiskFDAfda-F-0897-2023UNDECLARED ALLERGEN

Backpacker s Pantry Blueberry Peach Crisp, 4.6-ounce, packaged in a pouch, UPC-048143026143

Category
Units Affected
61,101
Recall Date
April 25, 2023
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0897-2023.

An almond allergen is missing from the Contains statement. The ingredient list on the package lists Almonds as an ingredient, however the Contains statement did not include Almond.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0897-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact American Outdoor Products, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0897-2023.

American Outdoor Products, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

American Outdoor Products, Inc. Recall FAQ

American Outdoor Products, Inc. is the subject of a produce safety report: Backpacker s Pantry Blueberry Peach Crisp, 4.6-ounce, packaged in a pouch, UPC-048143026143. The notice was published on April 25, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 61,101 units are potentially affected.